Opportunities and Challenges in Translational Research: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor Drugs

The development of photodynamic therapy and anti-vascular endothelial growth factor agents have revolutionized the treatment of retinal diseases, transforming the retina subspecialty by ushering in an age of pharmacological treatments for a wide range of diseases, including age-related macular degeneration (AMD).

Automated summary

The development of photodynamic therapy and anti-vascular endothelial growth factor agents has transformed the treatment of retinal diseases, introducing a new era of pharmacological treatments for a wide range of diseases including age-related macular degeneration (AMD).